{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T14:04:56Z","timestamp":1743516296422,"version":"3.38.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.beem.2025.101982","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T23:05:03Z","timestamp":1738364703000},"page":"101982","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Congenital primary hyperparathyroidism"],"prefix":"10.1016","volume":"39","author":[{"given":"Francesca","family":"Marini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Giusti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luisa","family":"Brandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.beem.2025.101982_bib1","first-page":"58","article-title":"Primary hyperparathyroidism","volume":"32","author":"Madkhali","year":"2016","journal-title":"Ulus Cerrah Derg"},{"issue":"5","key":"10.1016\/j.beem.2025.101982_bib2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.beem.2018.05.004","article-title":"Familial hypocalciuric Hypercalcemia and related disorders","volume":"32","author":"Lee","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101982_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/MED.0b013e32834c3c7c","article-title":"Familial hypocalciuric Hypercalcemia: a review","volume":"18","author":"Christensen","year":"2011","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.beem.2025.101982_bib4","doi-asserted-by":"crossref","first-page":"511","DOI":"10.7326\/0003-4819-102-4-511","article-title":"Familial benign Hypercalcemia (hypocalciuric Hypercalcemia): clinical and pathogenetic studies in 21 families","volume":"102","author":"Law","year":"1985","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.beem.2025.101982_bib5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/jbmr.3241","article-title":"Cinacalcet rectifies Hypercalcemia in a patient with familial Hypocalciuric Hypercalcemia Type 2 (FHH2) caused by a germline loss-of-function G\u03b111 mutation","volume":"33","author":"Gorvin","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"26","key":"10.1016\/j.beem.2025.101982_bib6","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","article-title":"Mutations affecting G-protein subunit alpha11 in Hypercalcemia and hypocalcemia","volume":"368","author":"Nesbit","year":"2013","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.beem.2025.101982_bib7","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1093\/hmg\/ddv226","article-title":"Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric Hypercalcemia type 3 (FHH3) demonstrate genotype-phenotype correlations, codon bias and dominant-negative effects","volume":"24","author":"Hannan","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.beem.2025.101982_bib8","article-title":"Meta-analysis of genome-wide association studies identifies six new Loci for serum calcium concentrations","volume":"9","author":"O\u2019Seaghdha","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.beem.2025.101982_bib9","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1172\/JCI118335","article-title":"V. Calcium-sensing receptor mutations in familial benign Hypercalcemia and neonatal hyperparathyroidism","volume":"96","author":"Pearce","year":"1995","journal-title":"J Clin Investig"},{"key":"10.1016\/j.beem.2025.101982_bib10","first-page":"627","article-title":"Early-onset, severe, and recurrent primary hyperparathyroidism associated with a novel CDC73 mutation","volume":"62","author":"Shibata","year":"2015","journal-title":"Endocrinol J"},{"key":"10.1016\/j.beem.2025.101982_bib11","series-title":"GeneReviews\u00ae [Internet]","article-title":"CDC73-Related Disorders","author":"Skefos","year":"2023"},{"issue":"3","key":"10.1016\/j.beem.2025.101982_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/jmg.2003.016725","article-title":"Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications","volume":"41","author":"Warner","year":"2004","journal-title":"J Med Genet"},{"issue":"3","key":"10.1016\/j.beem.2025.101982_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/jmg.2005.035766","article-title":"Familial isolated hyperparathyroidism is linked to a 1.7 Mb region on chromosome 2p13.3-14","volume":"43","author":"Warner","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/j.beem.2025.101982_bib14","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ajhg.2016.08.018","article-title":"GCM2-activating mutations in familial isolated hyperparathyroidism","volume":"99","author":"Guan","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"12","key":"10.1016\/j.beem.2025.101982_bib15","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1210\/clinem\/dgad368","article-title":"Phenotypic profiling and molecular mechanisms in Hyperparathyroidism-jaw Tumor Syndrome","volume":"108","author":"Tora","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101982_bib16","doi-asserted-by":"crossref","first-page":"602","DOI":"10.4158\/EP10337.RA","article-title":"Familial hyperparathyroidism due to a germline pathogenic variant of the CDC73 gene: implications for management and age-appropriate testing of relatives at risk","volume":"17","author":"Pichardo-Lowden","year":"2011","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2025.101982_bib17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/MPH.0000000000000443","article-title":"Parathyroid cancer in the pediatric patient","volume":"38","author":"Davidson","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"10.1016\/j.beem.2025.101982_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s42000-023-00508-9","article-title":"Genetics of hereditary forms of primary hyperparathyroidism","volume":"23","author":"English","year":"2024","journal-title":"Hormones"},{"issue":"4","key":"10.1016\/j.beem.2025.101982_bib19","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1210\/jc.2014-3659","article-title":"MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d\u2032\u00e9tude des Tumeurs Endocrines","volume":"100","author":"Goudet","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"21","key":"10.1016\/j.beem.2025.101982_bib20","doi-asserted-by":"crossref","first-page":"11586","DOI":"10.3390\/ijms252111586","article-title":"Molecular pathophysiology of parathyroid tumorigenesis-the lesson from a rare disease: the \"MEN1 Model\"","volume":"25","author":"Brunetti","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.beem.2025.101982_bib21","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00428-023-03730-3","article-title":"Syndromic MEN1 parathyroid adenomas consist of both subclonal nodules and clonally independent tumors","volume":"484","author":"Br\u00e4utigam","year":"2024","journal-title":"Virchows Arch"},{"key":"10.1016\/j.beem.2025.101982_bib22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijsu.2016.05.035","article-title":"Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; a clinico-pathologic challenge. The MD Anderson case series and review of the literature","volume":"31","author":"Christakis","year":"2016","journal-title":"Int J Surg"},{"issue":"7","key":"10.1016\/j.beem.2025.101982_bib23","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.3390\/cancers15072125","article-title":"Primary hyperparathyroidism in multiple endocrine neoplasia type 2A in Denmark 1930\u20132021: a Nationwide population-based retrospective study","volume":"15","author":"Holm","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.beem.2025.101982_bib24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng0194-70","article-title":"Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC","volume":"6","author":"Mulligan","year":"1994","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.beem.2025.101982_bib25","first-page":"1780","article-title":"Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. German Medullary Thyroid Carcinoma Study Group","volume":"81","author":"Frank-Raue","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2025.101982_bib26","first-page":"92","article-title":"Characteristics of primary hyperparathyroidism in multiple Endocrine Neoplasia Type 2A","volume":"34","author":"Haci\u015fahino\u011fullar\u0131","year":"2024","journal-title":"Turk J Ear Nose Throat"},{"issue":"12","key":"10.1016\/j.beem.2025.101982_bib27","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101982_bib28","unstructured":"Ahmed F.W., Majeed M.S., & Kirresh O. Multiple Endocrine Neoplasias Type 4. In StatPearls [Internet]; Last Update: October 18, 2023."},{"issue":"2","key":"10.1016\/j.beem.2025.101982_bib29","doi-asserted-by":"crossref","first-page":"K7","DOI":"10.1530\/EJE-14-0080","article-title":"A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome","volume":"171","author":"Tonelli","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2025.101982_bib30","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2008-2083","article-title":"Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states","volume":"94","author":"Agarwal","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2025.101982_bib31","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s40618-022-01948-7","article-title":"Novel germline variants of CDKN1B and CDKN2C identified during screening for familial primary hyperparathyroidism","volume":"46","author":"Mazarico-Altisent","year":"2022","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.beem.2025.101982_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1244361","article-title":"Genetic testing for familial hyperparathyroidism: clinical-genetic profile in a Mediterranean cohort","volume":"14","author":"Mazarico-Altisent","year":"2023","journal-title":"Front Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2025.101982_bib33","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1210\/clinem\/dgaa957","article-title":"Multiple endocrine tumors associated with germline MAX mutations: multiple Endocrine Neoplasia Type 5?","volume":"106","author":"Seabrook","year":"2021","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X25000156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X25000156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T09:32:57Z","timestamp":1741858377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X25000156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1521690X25000156"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2025.101982","relation":{},"ISSN":["1521-690X"],"issn-type":[{"type":"print","value":"1521-690X"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Congenital primary hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2025.101982","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101982"}}